Loomis, Sayles & Company’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20M | Sell |
549,538
-11,941
| -2% | -$434K | 0.03% | 244 |
|
|
2025
Q1 | $20.3M | Buy |
+561,479
| New | +$20.3M | 0.03% | 236 |
|
|
2023
Q4 | – | Sell |
-152
| Closed | -$5K | – | 1030 |
|
|
2023
Q3 | $5K | Buy |
152
+67
| +79% | +$2.2K | ﹤0.01% | 879 |
|
|
2023
Q2 | $4K | Buy |
+85
| New | +$4K | ﹤0.01% | 893 |
|
|
2019
Q4 | – | Sell |
-238,194
| Closed | -$10.2M | – | 758 |
|
|
2019
Q3 | $10.2M | Buy |
238,194
+18,940
| +9% | +$810K | 0.02% | 341 |
|
|
2019
Q2 | $13.9M | Buy |
+219,254
| New | +$13.9M | 0.03% | 274 |
|